SEC Form 4 · accession 0001019056-15-000525
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Aug 14, 2014
Accepted (ET)
May 27, 2015 · 12:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 14, 2014 | S | 2,785 | $28.85 | D | 531,945 | I | Footnote |
| Common StockF1 | Jan 5, 2015 | S | 2,518 | $27.05 | D | 529,427 | I | Footnote |
| Common StockF1 | Mar 20, 2015 | S | 4,010 | $39.15 | D | 525,417 | I | Footnote |
| Common StockF1 | Mar 30, 2015 | S | 4,761 | $38.90 | D | 520,656 | I | Footnote |
| Common StockF1 | Mar 31, 2015 | S | 2,000 | $39.15 | D | 518,656 | I | Footnote |
| Common StockF1 | Apr 1, 2015 | S | 1,100 | $39.00 | D | 517,556 | I | Footnote |
| Common StockF1 | Apr 6, 2015 | S | 2,000 | $39.25 | D | 515,556 | I | Footnote |
| Common StockF1 | Apr 7, 2015 | S | 4,400 | $39.70 | D | 511,156 | I | Footnote |
| Common StockF1 | Apr 8, 2015 | S | 2,500 | $39.69 | D | 508,656 | I | Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The above shares were sold by the Jeanette Vogel Family Trust for whom, Jeffrey K. Vogel is one of the Trustees.